Cullin 3 Exon 9 Deletion in Familial Hyperkalemic Hypertension Impairs Cullin3-Ring-E3 Ligase (CRL3) Dynamic Regulation and Cycling

Int J Mol Sci. 2022 May 5;23(9):5151. doi: 10.3390/ijms23095151.

Abstract

Cullin 3 (CUL3) is the scaffold of Cullin3 Ring E3-ligases (CRL3s), which use various BTB-adaptor proteins to ubiquitinate numerous substrates targeting their proteasomal degradation. CUL3 mutations, responsible for a severe form of familial hyperkalemia and hypertension (FHHt), all result in a deletion of exon 9 (amino-acids 403-459) (CUL3-∆9). Surprisingly, while CUL3-∆9 is hyperneddylated, a post-translational modification that typically activates CRL complexes, it is unable to ubiquitinate its substrates. In order to understand the mechanisms behind this loss-of function, we performed comparative label-free quantitative analyses of CUL3 and CUL3-∆9 interactome by mass spectrometry. It was observed that CUL3-∆9 interactions with COP9 and CAND1, both involved in CRL3 complexes' dynamic assembly, were disrupted. These defects result in a reduction in the dynamic cycling of the CRL3 complexes, making the CRL3-∆9 complex an inactive BTB-adaptor trap, as demonstrated by SILAC experiments. Collectively, the data indicated that the hyperneddylated CUL3-∆9 protein is inactive as a consequence of several structural changes disrupting its dynamic interactions with key regulatory partners.

Keywords: BTB protein; CRL complex; Cullin; WNK kinase; interactome.

MeSH terms

  • Cullin Proteins / genetics*
  • Cullin Proteins / metabolism
  • Exons / genetics
  • Female
  • Humans
  • Hypertension* / genetics
  • Male
  • Pseudohypoaldosteronism* / genetics
  • Pseudohypoaldosteronism* / metabolism
  • Ubiquitin-Protein Ligases / genetics

Substances

  • CUL3 protein, human
  • Cullin Proteins
  • Ubiquitin-Protein Ligases

Grants and funding

This work was supported by INSERM, the Fondation pour la Recherche pour l’Hypertension artérielle, Institut de Recherche Servier. Khalek was a recipient of a fellowship from Cardiovascular, obésité, rein, diabète; Domaine d’Intérêt Majeur, Région Ile de France. L.P. is head of Equipe labellisée Ligue contre le Cancer.